Literature DB >> 21334896

Discovery of histone deacetylase 8 selective inhibitors.

Weiping Tang1, Tuoping Luo, Edward F Greenberg, James E Bradner, Stuart L Schreiber.   

Abstract

We have developed an efficient method for synthesizing candidate histone deacetylase (HDAC) inhibitors in 96-well plates, which are used directly in high-throughput screening. We selected building blocks having hydrazide, aldehyde and hydroxamic acid functionalities. The hydrazides were coupled with different aldehydes in DMSO. The resulting products have the previously identified 'cap/linker/biasing element' structure known to favor inhibition of HDACs. These compounds were assayed without further purification. HDAC8-selective inhibitors were discovered from this novel collection of compounds.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21334896      PMCID: PMC3403710          DOI: 10.1016/j.bmcl.2011.01.134

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  49 in total

1.  Inhibitors of histone deacetylase are potentially effective anticancer agents.

Authors:  P A Marks; R A Rifkind; V M Richon; R Breslow
Journal:  Clin Cancer Res       Date:  2001-04       Impact factor: 12.531

Review 2.  The nucleosome: from genomic organization to genomic regulation.

Authors:  Sepideh Khorasanizadeh
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

3.  From knowing to controlling: a path from genomics to drugs using small molecule probes.

Authors:  Robert L Strausberg; Stuart L Schreiber
Journal:  Science       Date:  2003-04-11       Impact factor: 47.728

Review 4.  Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer.

Authors:  Saverio Minucci; Pier Giuseppe Pelicci
Journal:  Nat Rev Cancer       Date:  2006-01       Impact factor: 60.716

5.  Second generation hybrid polar compounds are potent inducers of transformed cell differentiation.

Authors:  V M Richon; Y Webb; R Merger; T Sheppard; B Jursic; L Ngo; F Civoli; R Breslow; R A Rifkind; P A Marks
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

6.  On the inhibition of histone deacetylase 8.

Authors:  Guillermina Estiu; Nathan West; Ralph Mazitschek; Edward Greenberg; James E Bradner; Olaf Wiest
Journal:  Bioorg Med Chem       Date:  2010-04-03       Impact factor: 3.641

7.  In vivo destabilization of dynamic microtubules by HDAC6-mediated deacetylation.

Authors:  Akihisa Matsuyama; Tadahiro Shimazu; Yuko Sumida; Akiko Saito; Yasuhiro Yoshimatsu; Daphné Seigneurin-Berny; Hiroyuki Osada; Yasuhiko Komatsu; Norikazu Nishino; Saadi Khochbin; Sueharu Horinouchi; Minoru Yoshida
Journal:  EMBO J       Date:  2002-12-16       Impact factor: 11.598

8.  Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors.

Authors:  M S Finnin; J R Donigian; A Cohen; V M Richon; R A Rifkind; P A Marks; R Breslow; N P Pavletich
Journal:  Nature       Date:  1999-09-09       Impact factor: 49.962

9.  Split--pool synthesis of 1,3-dioxanes leading to arrayed stock solutions of single compounds sufficient for multiple phenotypic and protein-binding assays.

Authors:  S M Sternson; J B Louca; J C Wong; S L Schreiber
Journal:  J Am Chem Soc       Date:  2001-02-28       Impact factor: 15.419

10.  Structural biasing elements for in-cell histone deacetylase paralog selectivity.

Authors:  Jason C Wong; Roger Hong; Stuart L Schreiber
Journal:  J Am Chem Soc       Date:  2003-05-14       Impact factor: 15.419

View more
  26 in total

1.  Extending Cross Metathesis To Identify Selective HDAC Inhibitors: Synthesis, Biological Activities, and Modeling.

Authors:  Samuel Bouchet; Camille Linot; Dusan Ruzic; Danica Agbaba; Benoit Fouchaq; Joëlle Roche; Katarina Nikolic; Christophe Blanquart; Philippe Bertrand
Journal:  ACS Med Chem Lett       Date:  2019-05-09       Impact factor: 4.345

Review 2.  Chemical probes and drug leads from advances in synthetic planning and methodology.

Authors:  Christopher J Gerry; Stuart L Schreiber
Journal:  Nat Rev Drug Discov       Date:  2018-04-13       Impact factor: 84.694

3.  Chromatin-targeting small molecules cause class-specific transcriptional changes in pancreatic endocrine cells.

Authors:  Stefan Kubicek; Joshua C Gilbert; Dina Fomina-Yadlin; Alexander D Gitlin; Yuan Yuan; Florence F Wagner; Edward B Holson; Tuoping Luo; Timothy A Lewis; Bradley Taylor; Supriya Gupta; Alykhan F Shamji; Bridget K Wagner; Paul A Clemons; Stuart L Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-20       Impact factor: 11.205

4.  Discovery of selective small-molecule HDAC6 inhibitor for overcoming proteasome inhibitor resistance in multiple myeloma.

Authors:  Teru Hideshima; Jun Qi; Ronald M Paranal; Weiping Tang; Edward Greenberg; Nathan West; Meaghan E Colling; Guillermina Estiu; Ralph Mazitschek; Jennifer A Perry; Hiroto Ohguchi; Francesca Cottini; Naoya Mimura; Güllü Görgün; Yu-Tzu Tai; Paul G Richardson; Ruben D Carrasco; Olaf Wiest; Stuart L Schreiber; Kenneth C Anderson; James E Bradner
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-31       Impact factor: 11.205

Review 5.  Role of histone deacetylases in pancreas: Implications for pathogenesis and therapy.

Authors:  Eckhard Klieser; Stefan Swierczynski; Christian Mayr; Johanna Schmidt; Daniel Neureiter; Tobias Kiesslich; Romana Illig
Journal:  World J Gastrointest Oncol       Date:  2015-12-15

6.  Potential non-oncological applications of histone deacetylase inhibitors.

Authors:  Katherine Ververis; Tom C Karagiannis
Journal:  Am J Transl Res       Date:  2011-10-10       Impact factor: 4.060

7.  Development of a Potent and Selective HDAC8 Inhibitor.

Authors:  Oscar J Ingham; Ronald M Paranal; William B Smith; Randolph A Escobar; Han Yueh; Tracy Snyder; John A Porco; James E Bradner; Aaron B Beeler
Journal:  ACS Med Chem Lett       Date:  2016-09-01       Impact factor: 4.345

8.  Radionuclide labeling and evaluation of candidate radioligands for PET imaging of histone deacetylase in the brain.

Authors:  Young Jun Seo; Lisa Muench; Alicia Reid; Jinzhu Chen; Yeona Kang; Jacob M Hooker; Nora D Volkow; Joanna S Fowler; Sung Won Kim
Journal:  Bioorg Med Chem Lett       Date:  2013-10-30       Impact factor: 2.823

9.  Novel analogs targeting histone deacetylase suppress aggressive thyroid cancer cell growth and induce re-differentiation.

Authors:  S Jang; X-M Yu; S Odorico; M Clark; R Jaskula-Sztul; C M Schienebeck; K R Kupcho; A D Harrison; G N Winston-McPherson; W Tang; H Chen
Journal:  Cancer Gene Ther       Date:  2015-08-07       Impact factor: 5.987

Review 10.  Epigenetic regulation of inflammation: progressing from broad acting histone deacetylase (HDAC) inhibitors to targeting specific HDACs.

Authors:  Melissa D Cantley; David R Haynes
Journal:  Inflammopharmacology       Date:  2013-01-23       Impact factor: 4.473

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.